 |
 |
 |
 |
|
|
|||
|
1. Evaluation of Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding in Subjects with Secondary Amenorrhea To be funded by: Solvay Pharmaceuticals Status: Pending study approval and approval from clinical trial and IRB offices.
2. A Twenty Four week, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Filbanserin (Dose to be determined by company once trial assigned) Milligrams Once Daily (Dose to be determined by company once trial assigned) Milligrams Twice Daily in Premenopausal Women with Hypoactive Sexual Desire Disorder To be funded by: Boehringer Ingelheim Status: Pending study approval and approval from clinical trial and IRB offices. Click for clinical trials website |
|
